Mylan would probably lower the price of EpiPens in the US and raise the prices in other countries if it were required to make its price the same for all countries. The reason for this is that Mylan would likely want to keep the price of EpiPens as high as possible to maximize profits. Therefore, by making the price the same for all countries, Mylan would be able to charge a higher price in countries with a lower standard of living and a lower price in countries with a higher standard of living